Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Moleculin Biotech Inc | 3 | 27 | 1 | 2 | €0.41 | €18.42 | 4393.659% |
| Evoke Pharma Inc. | 0 | 23 | 0 | 1 | €0.43 | - | - |
| InVivo Therapeutics Holdings | 1 | 17 | 0 | 0 | €0.33 | €1.60 | 379.042% |
| Trevena Inc. | 1 | 14 | 0 | 2 | €0.38 | €8.37 | 2104.585% |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| T2 Biosystems Inc. | 0 | 11 | 0 | 0 | €0.16 | - | - |
| BioLase Inc. | 0 | 7 | 0 | 1 | €0.067 | - | - |
| Organovo Holdings Inc. | 0 | 6 | 0 | 1 | €0.83 | - | - |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.38 | €7.00 | 194.118% |
| Fibrogen Inc. | 1 | 4 | 0 | 0 | €1.08 | €0.000 | -100.000% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €7.30 | €7.00 | -4.110% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.67 | - | - |
| Integra LifeSciences Holdings Corp | 3 | 5 | 0 | 2 | €23.00 | €34.68 | 50.776% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 1 | €0.49 | €2.79 | 472.169% |
| Cardiff Oncology Inc. | 2 | 4 | 1 | 1 | €2.94 | €5.00 | 70.068% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €1.07 | €6.49 | 504.709% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.66 | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.40 | - | - |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.53 | €3.00 | 462.430% |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.70 | - | - |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.44 | - | - |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.69 | - | - |
| Accelerate Diagnostics Inc. | 1 | 1 | 0 | 0 | €0.88 | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.05 | €3.00 | 46.056% |
| Neogen Corp. | 1 | 1 | 0 | 0 | €11.40 | €20.08 | 76.174% |